258 related articles for article (PubMed ID: 36073220)
1. [Honokiol reduces doxorubicin-induced cardiotoxicity
Xiong F; Liu R; Li Y; Sun N
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1205-1211. PubMed ID: 36073220
[TBL] [Abstract][Full Text] [Related]
2. Mitochonic acid 5 rescues cardiomyocytes from doxorubicin-induced toxicity via repressing the TNF-α/NF-κB/NLRP3-mediated pyroptosis.
Zha W; Zhao Q; Xiao Y; Gan Y; Wei J; Yu M; Xu Y; Xu Q; Wu S; Yu W
Int Immunopharmacol; 2023 Oct; 123():110736. PubMed ID: 37549513
[TBL] [Abstract][Full Text] [Related]
3. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis.
Tavakoli Dargani Z; Singla DK
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H460-H471. PubMed ID: 31172809
[TBL] [Abstract][Full Text] [Related]
4. [Hesperetin Alleviates Doxorubicin-Induced Cytotoxicity in H9c2 Cells by Activating SIRT1/NRF2 Signaling].
Li X; Yan A; Chang J; Li F; Zhu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):947-953. PubMed ID: 37866951
[TBL] [Abstract][Full Text] [Related]
5. Exogenous 8-hydroxydeoxyguanosine attenuates doxorubicin-induced cardiotoxicity by decreasing pyroptosis in H9c2 cardiomyocytes.
Hwang S; Kim SH; Yoo KH; Chung MH; Lee JW; Son KH
BMC Mol Cell Biol; 2022 Dec; 23(1):55. PubMed ID: 36517746
[TBL] [Abstract][Full Text] [Related]
6. Amentoflavone mitigates doxorubicin-induced cardiotoxicity by suppressing cardiomyocyte pyroptosis and inflammation through inhibition of the STING/NLRP3 signalling pathway.
Fang G; Li X; Yang F; Huang T; Qiu C; Peng K; Wang Z; Yang Y; Lan C
Phytomedicine; 2023 Aug; 117():154922. PubMed ID: 37321078
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3.
Meng L; Lin H; Zhang J; Lin N; Sun Z; Gao F; Luo H; Ni T; Luo W; Chi J; Guo H
J Mol Cell Cardiol; 2019 Nov; 136():15-26. PubMed ID: 31445005
[TBL] [Abstract][Full Text] [Related]
8. [Impact and related mechanism on the improvement of hyperglycemia-induced pyroptosis in H9c2 cells by mircoRNA-214].
Wang Y; Zhao RZ; Chen PK; Xu GX; Liu ZJ; Long XP; Qiu ZM; Shi B
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Oct; 47(10):820-828. PubMed ID: 31648465
[No Abstract] [Full Text] [Related]
9. Carnosic acid protects against doxorubicin-induced cardiotoxicity through enhancing the Nrf2/HO-1 pathway.
Hu S; Liu B; Yang M; Mao S; Ju H; Liu Z; Huang M; Wu G
Food Funct; 2023 Apr; 14(8):3849-3862. PubMed ID: 37013966
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of thiolutin on doxorubicin-induced H9c2 cardiomyocyte injury.
Cai W; Teng T; Wang X; Li B; Gu X; Zhou Y
J Toxicol Sci; 2023; 48(8):469-479. PubMed ID: 37532580
[TBL] [Abstract][Full Text] [Related]
11. Calycosin Alleviates Doxorubicin-Induced Cardiotoxicity and Pyroptosis by Inhibiting NLRP3 Inflammasome Activation.
Zhang L; Fan C; Jiao HC; Zhang Q; Jiang YH; Cui J; Liu Y; Jiang YH; Zhang J; Yang MQ; Li Y; Xue YT
Oxid Med Cell Longev; 2022; 2022():1733834. PubMed ID: 35035656
[TBL] [Abstract][Full Text] [Related]
12. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway.
Gu J; Huang H; Liu C; Jiang B; Li M; Liu L; Zhang S
Int Immunopharmacol; 2021 Jun; 95():107533. PubMed ID: 33752080
[TBL] [Abstract][Full Text] [Related]
13. Allicin protects against LPS-induced cardiomyocyte injury by activating Nrf2-HO-1 and inhibiting NLRP3 pathways.
Sun F; Xu K; Zhou J; Zhang W; Duan G; Lei M
BMC Cardiovasc Disord; 2023 Aug; 23(1):410. PubMed ID: 37596540
[TBL] [Abstract][Full Text] [Related]
14. Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity.
Wei S; Ma W; Li X; Jiang C; Sun T; Li Y; Zhang B; Li W
Cardiovasc Toxicol; 2020 Oct; 20(5):507-519. PubMed ID: 32607760
[TBL] [Abstract][Full Text] [Related]
15. Trastuzumab potentiates doxorubicin-induced cardiotoxicity via activating the NLRP3 inflammasome in vivo and in vitro.
Wei S; Ma W; Yang Y; Sun T; Jiang C; Liu J; Zhang B; Li W
Biochem Pharmacol; 2023 Aug; 214():115662. PubMed ID: 37331637
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin ameliorates high glucose- and ischemia/reperfusion-induced myocardial injury by suppressing pyroptosis via AMPK signaling pathway.
Yao M; Wang Z; Jiang L; Wang L; Yang Y; Wang Q; Qian X; Zeng W; Yang W; Liang R; Qian J
Biomed Pharmacother; 2022 Sep; 153():113498. PubMed ID: 36076588
[TBL] [Abstract][Full Text] [Related]
17. ALDH2 Overexpression Alleviates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation.
Cao R; Fang D; Wang J; Yu Y; Ye H; Kang P; Li Z; Wang H; Gao Q
J Diabetes Res; 2019; 2019():4857921. PubMed ID: 31871948
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine reduces the inflammation and apoptosis of doxorubicin-induced myocardial cells.
He Y; Yang Z; Li J; Li E
Exp Mol Pathol; 2020 Apr; 113():104371. PubMed ID: 31917290
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway.
Jiang Q; Chen X; Tian X; Zhang J; Xue S; Jiang Y; Liu T; Wang X; Sun Q; Hong Y; Li C; Guo D; Wang Y; Wang Q
Phytomedicine; 2022 Nov; 106():154439. PubMed ID: 36108374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
